Our Pricing

Buy Mounjaro Northern Ireland - GPhC Registered Pharmacy

When you buy Mounjaro Northern Ireland online pharmacy services from Cured Pharmacy, you're accessing genuine UK-licensed tirzepatide injections with transparent pricing from £135.00 delivered discreetly to your NI address. Our GPhC-registered pharmacy (9012511) connects Northern Ireland patients with UK prescribers for fast, confidential weight loss treatment assessments completed in under 3 minutes.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURPASS-2 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than the 15.8% reduction observed with semaglutide 1mg in head-to-head comparison [1]. Clinical data from the SURMOUNT-1 trial demonstrated that 63% of patients on the highest tirzepatide dose achieved at least 20% total body weight loss, compared to just 1.3% in the placebo group [2].

The medication works by slowing gastric emptying, reducing appetite signals in the brain, and improving post-meal blood sugar control. Most patients report feeling fuller for longer periods and experiencing fewer food cravings within the first 2-4 weeks of treatment, though individual responses vary and require ongoing monitoring by a UK prescriber.

Mounjaro Pricing and Availability in Northern Ireland

At Cured Pharmacy, Mounjaro is available from £135.00 with transparent upfront pricing displayed before your clinical consultation begins. This represents competitive UK pricing with no hidden fees or surprise charges at checkout. Your final cost depends on the prescribed dose strength — starting doses typically begin at 2.5mg weekly, with gradual titration to maintenance doses of 5mg, 7.5mg, 10mg, 12.5mg, or 15mg based on your clinical response and tolerability.

Northern Ireland residents benefit from the same UK pharmacy regulations as the rest of the country, meaning all Mounjaro pens dispensed by Cured Pharmacy are genuine UK-licensed medications sourced through regulated supply chains. We deliver discreetly to all NI postcodes using tracked courier services, with most orders arriving within 2-4 working days of prescriber approval.

Unlike some online services that require monthly subscriptions or long-term commitments, Cured Pharmacy offers flexible ordering with no obligation to continue beyond your current prescription period. You'll always see the exact price before completing your free consultation, and our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees every dispensing decision to ensure clinical appropriateness.

Why Prices Vary Between Pharmacies

Mounjaro pricing across UK online pharmacies reflects differences in operational costs, sourcing arrangements, and service models rather than medication quality — all legitimate UK pharmacies must dispense the same MHRA-licensed product. At Cured Pharmacy, our lowest price guarantee means you're getting competitive rates without compromising on clinical safety, prescriber expertise, or regulatory compliance.

The Online Consultation Process for Northern Ireland Patients

Mounjaro is a prescription-only medication in the UK, requiring clinical assessment by a registered prescriber before it can be legally dispensed. Our online consultation takes under 3 minutes to complete and asks clinically relevant questions about your weight history, current medications, cardiovascular health, and previous weight loss attempts.

The consultation form is reviewed by UK-registered prescribers who assess your suitability based on NICE guidance for weight management medications. You'll need a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. The prescriber may request additional information or suggest alternative treatments if Mounjaro isn't clinically appropriate for your individual circumstances.

Once approved, your prescription is electronically transmitted to our GPhC-registered pharmacy where it's dispensed by qualified pharmacists and dispatched the same working day in most cases. You'll receive tracking information via email and can contact our clinical team on (+44) 116 4646009 if you have questions about administration technique, side effect management, or dose titration schedules.

What Happens If You're Not Approved

If a prescriber determines that Mounjaro isn't suitable based on your medical history, they may recommend alternative treatments such as Wegovy, Saxenda, or oral medications like Orlistat. You won't be charged for consultations that don't result in a prescription, and our clinical team will explain the reasoning behind any decision to help you explore other evidence-based weight management options.

Mounjaro Dosing Schedule and Administration

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. The standard titration schedule begins with 2.5mg weekly for four weeks, increasing to 5mg for the next four weeks, then continuing stepwise escalation every four weeks until you reach your maintenance dose [3]. This gradual approach minimises gastrointestinal side effects such as nausea and vomiting, which are most common during dose increases.

Each KwikPen contains four weekly doses and should be stored in the refrigerator between 2°C and 8°C until first use. You can inject into your abdomen, thigh, or upper arm, rotating injection sites each week to reduce the risk of lipodystrophy. The injection itself takes only seconds and uses a fine 32-gauge needle that most patients find comfortable after the first few administrations.

Your prescriber will provide specific instructions on when to increase your dose based on your weight loss progress and side effect profile. Some patients remain on lower maintenance doses if they achieve satisfactory results, while others benefit from escalation to 12.5mg or 15mg weekly. Regular follow-up consultations every 8-12 weeks ensure your treatment remains clinically appropriate and effective.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Mounjaro are gastrointestinal in nature, including nausea (experienced by up to 33% of patients in clinical trials), diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These effects are typically mild to moderate, occur most commonly during the first 8-12 weeks of treatment, and diminish as your body adapts to the medication.

To minimise nausea, eat smaller, more frequent meals rather than large portions, avoid high-fat or spicy foods, and stay well-hydrated throughout the day. If nausea persists beyond the first month or significantly impacts your quality of life, contact your prescriber — they may recommend temporarily pausing dose escalation or prescribing anti-nausea medication such as domperidone or prochlorperazine for short-term use.

Rare but serious side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, and hypoglycaemia if you're taking Mounjaro alongside other diabetes medications. Seek immediate medical attention if you experience persistent severe abdominal pain, yellowing of the skin or eyes, or symptoms of low blood sugar such as confusion, sweating, or rapid heartbeat. Our clinical team is available to discuss any concerns during your treatment journey.

When to Stop Treatment and Seek Medical Advice

Discontinue Mounjaro and contact a healthcare professional immediately if you develop signs of thyroid tumours (lump in the neck, difficulty swallowing, persistent hoarseness), severe allergic reactions (facial swelling, difficulty breathing, widespread rash), or acute pancreatitis. While these events are rare, early recognition and appropriate medical management are essential for patient safety.

Comparing Weight Loss Treatments Available in Northern Ireland

Northern Ireland patients have access to several evidence-based weight loss medications through UK-registered online pharmacies, each with distinct mechanisms of action and clinical profiles. Mounjaro offers the highest average weight loss in clinical trials but comes at a premium price point. Wegovy (semaglutide) provides excellent efficacy with once-weekly dosing and is available from £135.00 making it a cost-effective alternative for many patients.

Saxenda (liraglutide) requires daily injections rather than weekly administration, which some patients find less convenient despite its lower starting price from £135.00. For those who prefer oral medications or have concerns about injections, Orlistat and Xenical work by blocking dietary fat absorption in the intestine, though they produce more modest weight loss (typically 5-10% of body weight) compared to GLP-1 receptor agonists [4].

Your prescriber will consider factors including your BMI, weight loss goals, previous treatment responses, budget constraints, and personal preferences when recommending the most suitable option. Many patients achieve excellent results with any of these medications when combined with dietary modifications and increased physical activity — the best treatment is the one you can adhere to consistently over the long term.

Can You Switch Between Treatments

Switching from one weight loss medication to another is possible under prescriber supervision, though transition protocols vary depending on the medications involved. If you're moving from Wegovy to Mounjaro, for example, your prescriber may recommend a brief washout period or starting Mounjaro at a lower dose to assess tolerability. Always consult your UK prescriber before making any changes to your treatment regimen.

Scientific References

1. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14298
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.